• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Antiglucocorticoid action of RU 486].

作者信息

Bertagna X

机构信息

Centre de Recherches sur les Maladies Endocriniennes, Hôpital Cochin, Paris.

出版信息

Ann Endocrinol (Paris). 1989;50(3):208-17.

PMID:2554782
Abstract

RU 486 is a synthetic steroid molecule with high affinity to the glucocorticoid receptor and which exerts an antiglucocorticoid activity. In animals RU 486 constantly inhibits the various effects induced by dexamethasone in classical experimental models. Its mechanism of action is not totally elucidated: RU 486 seems to inhibit both the glucocorticoid receptor activation and the gene transcription phenomenon. The antiglucocorticoid action of RU 486 in man was first demonstrated by studying the corticotropic response: a single dose of 400 mg of RU 486, given at 0200 h, triggers a corticotropic retort as if the pituitary felt it was deprived of cortisol. RU 486 inhibits, in a dose-dependent manner, various biological responses acutely induced by dexamethasone in man: corticotropic suppression, skin blanching, circulating oesinophils drop. RU 486 suppresses the peripheral features of chronic hypercortisolism in non-pituitary dependent Cushing's syndromes. In Cushing's disease administration of RU 486 immediately induces a strong and long lasting corticotropic (and cortisol) rise, especially since the drug has a long plasma half-life. This inescapable pituitary retort is a major drawback which suggests that chronic RU 486 administration will always and inevitably induce the secretion of its own antidote...cortisol!

摘要

相似文献

1
[Antiglucocorticoid action of RU 486].
Ann Endocrinol (Paris). 1989;50(3):208-17.
2
The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.抗糖皮质激素和抗孕激素甾体药物RU 486可抑制人体对羊促肾上腺皮质激素释放激素的促肾上腺皮质激素反应。
J Clin Endocrinol Metab. 1988 Feb;66(2):290-3. doi: 10.1210/jcem-66-2-290.
3
Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.正常志愿者连续8天服用RU 486:具有抗糖皮质激素作用,且无外周皮质醇缺乏的证据。
J Clin Endocrinol Metab. 1994 Feb;78(2):375-80. doi: 10.1210/jcem.78.2.8106625.
4
Transient inhibition of RU 486 antiglucocorticoid action by dexamethasone.地塞米松对RU 486抗糖皮质激素作用的短暂抑制。
J Clin Endocrinol Metab. 1990 Jan;70(1):230-3. doi: 10.1210/jcem-70-1-230.
5
Pituitary-adrenal response to the antiglucocorticoid action of RU 486 in Cushing's syndrome.垂体 - 肾上腺对RU 486在库欣综合征中抗糖皮质激素作用的反应。
J Clin Endocrinol Metab. 1986 Sep;63(3):639-43. doi: 10.1210/jcem-63-3-639.
6
The new steroid analog RU 486 inhibits glucocorticoid action in man.新型类固醇类似物RU 486可抑制人体中的糖皮质激素作用。
J Clin Endocrinol Metab. 1984 Jul;59(1):25-8. doi: 10.1210/jcem-59-1-25.
7
Mifepristone: treatment of Cushing's syndrome.米非司酮:库欣综合征的治疗
Clin Obstet Gynecol. 1996 Jun;39(2):506-10. doi: 10.1097/00003081-199606000-00024.
8
The glucocorticoid receptor and RU 486 in man.人体内的糖皮质激素受体与米非司酮
Ann N Y Acad Sci. 1995 Jun 12;761:296-310. doi: 10.1111/j.1749-6632.1995.tb31385.x.
9
RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism.RU 486可预防皮质醇对葡萄糖和亮氨酸代谢的急性影响。
J Clin Endocrinol Metab. 1995 Feb;80(2):379-85. doi: 10.1210/jcem.80.2.7888013.
10
The antiglucocorticoid and antiprogestin steroid RU 486: its glucocorticoid agonist effect is inadequate to prevent adrenal insufficiency in primates.抗糖皮质激素和抗孕激素类固醇RU 486:其糖皮质激素激动剂作用不足以预防灵长类动物的肾上腺功能不全。
J Clin Endocrinol Metab. 1988 Sep;67(3):602-6. doi: 10.1210/jcem-67-3-602.

引用本文的文献

1
Growth and differentiation of C2 myogenic cells are dependent on serum response factor.C2 成肌细胞的生长与分化依赖于血清反应因子。
Mol Cell Biol. 1996 Nov;16(11):6065-74. doi: 10.1128/MCB.16.11.6065.